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Background: Osteoarthritis (OA), a disease with whole-joint damage and dysfunction, is the leading cause of
disability worldwide. The progressive loss of hyaline cartilage extracellular matrix (ECM) is considered as its
hallmark, but its exact pathogenesis needs to be further clarified. MicroRNA(miRNA) contributes to OA
pathology and may help to identify novel biomarkers and therapies against OA. Here we identified miR-
2143p as an important regulator of OA.
Methods: qRT-PCR and in situ hybridization were used to detect the expression level of miR-2143p. The
function of miR-2143p in OA, as well as the interaction between miR-2143p and its downstream mRNA
target (IKBKB), was evaluated by western blotting, immunofluorescence, qRT-PCR and luciferase assay. Mice
models were introduced to examine the function and mechanism of miR-2143p in OA in vivo.
Findings: In our study, we found that miR-2143p, while being down-regulated in inflamed chondrocytes
and OA cartilage, regulated ECM metabolism and cell apoptosis in the cartilage. Mechanically, the protective
effect of miR-2143p downregulated the IKK-b expression and led to the dysfunction of NF-kB signaling
pathway. Furthermore, intra-articular injection of miR-2143p antagomir in mice joints triggered spontane-
ous cartilage loss while miRNA-2143p agomir alleviated OA in the experimental mouse models.
Interpretation: Decreased miR-2143p activates the NF-kB signaling pathway and aggravates OA develop-
ment through targeting IKKb, suggesting miR-2143p may be a novel therapeutic target for OA.
Funding: This study was financially supported by grants from the National Natural Science Foundation of
China (81,773,532, 81,974,342).







V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)1. Introduction
Osteoarthritis (OA) is a highly prevalent joint disorder with
whole-joint damage and dysfunction, mainly presented in aged pop-
ulation, leading to chronic pain, joint stiffness, and severe physical
disability [1,2]. It is characterized by the loss of articular cartilage in
addition to other joint disruption, including subchondral bone
remodeling, osteophyte formation, synovium inflammation and
meniscal damage [3,4]. Present OA management is widely divided
into nonpharmacological, pharmacological, and surgical treatments
[5,6]. Nonpharmacological treatments, such as exercise, weight loss,and physical therapy, are recommended for early-stage OA patients.
Pharmacological treatments are mainly focused on pain management
with analgesics and anti-inflammatory medication. Surgical treat-
ment is most widely used for patients in the late phase of the disease
process [7,8]. However, the specific mechanisms leading to OA have
not been fully elucidated, current OA treatments are limited and
insufficient to prevent the initiation and progression of the disease.
Thus, further study on pathogenesis of the disease and exploring new
therapeutic strategies is of great clinical significance.
MicroRNAs (miRNAs), approximately 22 nucleotides (nt) long, are
a class of non-coding, single- stranded RNAs, which repress mRNA
translation or promote its degradation by interacting with the 30
untranslated regions (UTRs) of the target genes [9,10]. Recent studies
have shown that miRNAs are involved in the development and pro-
gression of OA by regulating chondrocyte apoptosis and proliferation,
Research in context
Evidence before this study
An increasing number of studies have revealed that miRNA is
tightly associated with the initiation and progression of OA,
but its effect and underlying mechanism remain unclear.
Recent studies on other diseases have demonstrated that
miR-2143p has the ability to regulate numerous targets in
pathogenesis of disease. As cartilage deterioration is a key
pathogenic event in the development of OA, we investigated
the mechanical role of miR-2143p expression on articular
cartilage degradation and cell apoptosis.
Added values of this study
Our in vitro and in vivo studies demonstrated that miR-2143p
could effectively protect the cartilage from damage through
inhibition of NF-kB signaling pathway, and the miR-2143p/
IKKb/NF-kB axis may represent a promising potential thera-
peutic target.
Implications of all the available evidence
This is the first report of a role for miR-2143p in the regulation
of cartilage metabolism in OA, with specific relevance to a com-
mon arthritis disease impacting on human health. Its protective
effect was mediated by targeting IKKb, leading to the blockage
of NF-kB signaling pathway. These data suggest that the miR-
2143p/IKKb/NF-kB axis may stand for a novel opportunity for
intervention of OA and other inflammatory arthritis diseases.
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[1113]. Thus, revealing the roles of miRNAs and their potential tar-
get regulators is critical for understanding the molecular mechanisms
of OA and identifying new biomarkers or therapeutic targets for OA.
The nuclear factor-kappa B (NF-kB) signaling is essential in a wide
range of biological processes, such as ECM degradation, cell cycle pro-
gression, apoptosis and inflammation [14,15]. Under the stimulation
of inflammatory factors, the inhibitor of nuclear factor kappa B kinase
(IKK) complex leads to IkBa phosphorylated in the cytoplasm and
degraded subsequently. The NF-kB dimers are then released into the
nucleus, resulting in the transcription of downstream target genes
[16,17]. As a key catalytic subunit of IKK complex, IKKb functions cru-
cially in NF-kB activation and in many diseases [18,19]. Researchers
have found that several miRNAs target IKKb, such as miR-199b and
miR-200b, in some disorders [20,21]. Previous studies have con-
firmed that NF-kB signaling is implicated in OA pathophysiology
through various effects and thus representing a potential therapeutic
target for OA treatment [2224]. However, the molecular mechanism
in regulating IKKb/NF-kB pathway in OA remains poorly understood.
In the present study, we identified a miRNA, miR-2143p, which
was significantly downregulated in IL-1b-treated chondrocytes and
cartilage tissues from OA patients and the experimental mouse mod-
els. Furthermore, we investigated that downregulation of miR-2143p
activated the NF-kB signaling pathway and aggravated OA develop-
ment through targeting IKKb. We believe our findings provide new
insights into the role of miRNAs and the IKKb/NF-kB pathway in OA
and are valuable for developing novel therapeutic strategies.
2. Materials and methods
2.1. Ethics
This study was approved by the Ethics Committees of Zhujiang
Hospital, Southern Medical University, and all aspects of the studycomply with the criteria established by the Declaration of Helsinki.
The OA patients provided informed consent to participate in this
study. The human knee cartilage study was approved by the Ethics
Committee of Zhujiang Hospital, Southern Medical University
(Guangzhou, China) (2019-KY-02203). Animal handling and experi-
mental procedures were performed with the approval from Zhujiang
Hospital of Southern Medical University Ethics Committee (LAEC-
2019004).
2.2. Human cartilage tissue collection
OA cartilage samples were aseptically collected from patients
undergoing total knee replacement surgery for end-stage knee OA
(n = 30). The human knee cartilage study was approved by the Ethics
Committee of Zhujiang Hospital, Southern Medical University
(Guangzhou, China) (2019-KY-02203). Written informed consent
was obtained from all patients. The inclusion criteria included: 1) age
4579, gender unlimited; 2) knee pain and other manifestations of
arthritis. Secondary OA and other inflammatory joint diseases were
ruled out based on clinical data. Clinical characteristics of the patients
were collected as Supplementary Table S1. Human knee cartilage tis-
sues of undamaged and damaged areas were fixed in 4% paraformal-
dehyde (PFA) for 36 h, and then changed to decalcification solution.
Safranin O/Fast Green or RNA in situ hybridization were performed
on these human articular cartilage tissue sections.
2.3. Human primary chondrocyte isolation and cell culture
Human chondrocytes (HCs) were isolated and cultured according
to previous protocols [25]. Human cartilages of undamaged areas
were eliminated under sterile conditions. Subsequent to the elimina-
tion of connective tissue, as well as perichondrium, rest of the carti-
lages were minced and washed thrice with PBS. Tissues were
digested by trypsin (Gibco Life Technology, NY) for 20 min. Subse-
quent to supernatant elimination, PBS was utilized to wash the carti-
lages. Using a three to five times volume of a type II collagenase
solution (ThermoFisher, NY), a twelve-hour digestion was carried out
at 37 °C. The cell suspension was centrifuged at 40 g for 5 min, the
supernatant was taken to another centrifuge tube, remaining cells
continued to be digested, and the cells were harvested again after
24 h. Centrifuged the supernatant at 300 g for 5 min, poured out the
excess liquid, resuspended the cell pellet with 5 mL DMEM/F12
(Gibco Life Technology, NY) containing 10% fetal bovine serum (Gibco
Life Technology, NY), and cultured in 25 cm2 culture flasks in a 37 °C
humidified atmosphere with 5% CO2. The mediumwas changed every
3 days.
2.4. Primary culture of mice chondrocytes
Femoral heads and femoral condyles of C57BL/6 newborn mice
were used to isolate primary chondrocytes as described previously
[26]. The basic procedure is similar to that described above for the
extraction of human chondrocytes. After isolation, cells were cultured
in 25 cm2 culture flasks with DMEM/F12 (Gibco Life Technology, NY)
containing 10% fetal bovine serum (Gibco Life Technology, NY). Non-
adherent cells were removed, and adherent chondrocytes were cul-
tured and expanded for further experiments. Primary cells were used
in the experiments prior to the second passage. Primary chondrocyte
from human and mice were validated by immunofluorescence of
type II collagen and Toluidine blue staining.
2.5. RNA extraction and quantitative real-time polymerase chain
reaction (qRT-PCR)
Total RNA was isolated from human and mice chondrocytes using
the TRIzol kit (TaKaRa, Japan) according to the manufacturer’s
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total RNA and a PrimeScript RT Reagent Kit (TAKARA) or PrimeScript
RT Master Mix (TAKARA), which were used to investigate the expres-
sion of miRNA and mRNA, respectively. For miRNA assay, the reverse
reactions were incubated at 42 °C for 15 min followed by inactivation
at 85 °C for 5 s. qRT-PCR amplification was assessed in a CFX Connec-
tion Real-Time System (Bio-Rad) by using the SYBR Premix Ex Taq II
kit (TaKaRa). The following cycling conditions were used: 95 °C for
30 s, followed by 40 cycles of 95 °C for 5 s and 60 °C for 30 s. All reac-
tions were performed in duplicate and normalized to the internal ref-
erence U6 for miRNA and GAPDH for mRNAs. The 244Ct method
was used to evaluate the relative mRNA/miRNA expression levels.
Primers are listed in Supplementary Table S2A.
2.6. In situ hybridization (ISH)
Both human and mouse knee tissues were fixed with 4% PFA fol-
lowed by decalcification with ethylenediaminetetraacetic acid
(EDTA). ISH was used to evaluate miR-2143p expression levels
based on the manufacturer’s protocol (Boster Biological Technology
Co., Ltd, China) as described previously [27]. Briefly, the endogenous
peroxidase activity was blocked with 3% hydrogen peroxide for
10 min, and then the slices were digested with pepsin diluted with
3% citric acid for 30 min at 37 °C. The sections were fixed with 4% PFA
containing 1/1000 diethylpyrocarbonate (DEPC) at room temperature
for 10 min, and then prehybridized solution was added for incubation
at 42 °C for 2 h. After hybridizing with miR-2143p probe at 42 °C
overnight, the sections were washed with SSC, and then the blocking
solution, biotinylated mouse anti digoxin, strept avidin-biotin com-
plex and biotinylated peroxidase were added successively. Finally,
the slides were stained with DAB. The sections were dehydrated and
observed using a microscope.
2.7. MiRNAs transfection and cell treatments
HCs were seeded in 6-well plate at density of 1.5 £ 105/well to
reach about 70% confluence after 48 h. Then cells were transfected
with miR-2143p mimic, scramble, miR-2143p inhibitor and nega-
tive control (GenPharma Co. Shanghai, China) at a concentration of
30 nM by using Lipofectamine 2000 reagents (Life Technologies Cor-
poration, Carlsbad, CA, USA) according to the manufacturer’s instruc-
tions. Cells were cultured with IL-1b (Sigma-Aldrich, St. Louis, Mo,
USA) at the concentration of 10 ng/mL for 24 h before harvested.
After 48 h transfection, the cells were collected and then were used
for further experiments. All miRNA sequences were listed in Supple-
mentary Table S2B.
2.8. Western blotting
Proteins were extracted from HCs by radio-immunoprecipitation
assay buffer (RIPA, Beyotime, China), and protein concentrations
were quantified by bicinchoninic acid (BCA) protein assay kit (Beyo-
time, China). Protein components were separated by 10% or 12% SDS-
PAGE gels and transferred onto polyvinylidene fluoride (PVDF) mem-
branes (Immobilon P, Millipore). Membranes were blocked in 10 mM
Tris-buffered saline (TBS) containing 5% nonfat skimmed milk and
probed for 2 h. After the incubation with a high affinity anti-COL2A1
antibody (1:1000, Abcam Cat# ab34712, RRID: AB_731,688), anti-
SOX9 (1:1000, Proteintech Cat# 67,4391-lg, RRID: AB_2,882,675),
anti-MMP13 antibody (1:1000, Abcam Cat# ab84594, RRID:
AB_10,562,126), anti-MMP3 antibody (1:1000, Abcam Cat# ab52915,
RRID: AB_881,243), anti-cleaved-Caspase 3 (1:1000, Proteintech Cat#19,6771-AP, RRID: AB_10,733,244), anti-Bcl-2 (1:1000, Proteintech
Cat# 12,7891-AP, RRID: AB_2,227,948), anti-IKKb (1:1000, Abcam
Cat# ab124957, RRID:AB_10,975,710), anti-p-iKBa (1:1000, Cell Sig-
naling Technology Cat# 2859, RRID: AB_561,111), anti-p-p65
(1:1000, Cell Signaling Technology Cat# 3033, RRID: AB_331,284),
anti-p65 (1:1000, Cell Signaling Technology Cat# 8242, RRID:
AB_10,859,369), and anti-GAPDH antibody (1:5000, Proteintech Cat#
60,0041-Ig, RRID:AB_2,107,436) in 5% BSA dilution at 4 °C over-
night, washed with TBST, and then incubated with a secondary anti-
body (1:5000, ABclonal Cat# AS014, RRID: AB_2,769,854; ABclonal
Cat# AS003, RRID: AB_2,769,851) for 1 h at room temperature. After
washes, enhanced chemiluminescent imaging of the blots were
detected using ECL (merck millipore) and a chemiluminescence sys-
tem (Bio-Rad, USA) and processed using Image Lab Software.2.9. Immunofluorescence staining
HCs were seeded on 15 mm cell slides (Nest Biotechnology) in 24-
well plates. 4% PFA was first used to fix cells for 15 min, and 0.5% Tri-
ton X-100 was performed to permeate cells for 20 min. After blocked
by 5% BSA for 30 min, chondrocytes were incubated with a primary
antibody at 4 °C overnight and then with fluorescent Alexa Fluor
555-conjugated secondary antibody in dark at 37 °C for 1 h. The anti-
bodies used were anti-IKKb (1:200, Abcam Cat# ab124957, RRID:
AB_10,975,710), anti-p65(1:400, Cell Signaling Technology Cat#
8242, RRID: AB_10,859,369), and fluorescent Alexa Fluor 555-conju-
gated secondary goat anti-rabbit antibodies (1:500, Cell Signaling
Technology Cat# 4413, RRID: AB_ 10,694,110). Fluorescence images
were obtained using Nikon Ti2-E.2.10. Apoptosis detection
Apoptosis was detected using the Caspase-3/7 cell apoptosis
detection kit (RiboAPO, China) according to the manufacturer’s
instructions. Briefly, we removed the common medium, added mixed
staining medium into each well, and incubated at 37 °C for 45 min.
During dyeing and incubation, we diluted reagent B with fresh
medium at the ratio of 100:1 to prepare an appropriate amount of
1 £ PI staining medium. After incubation, removed the mixed stain-
ing medium, added 1 £ PI staining medium into each well, and incu-
bated at room temperature for 5 min. Washed twice with PBS
carefully, and replaced it with fresh medium. Specimens were
detected by fluorescence microscopy Nikon Ti2-E. Caspase-3/7 green
fluorescence, PI red fluorescence and hoechst33342 blue fluorescence
could distinguish apoptotic cells, dead cells and living cells, respec-
tively.2.11. Luciferase assay
HEK-293T cells were seeded in 6-well plates 24 h before transfec-
tion. 500 ng plasmids of IKBKB 30UTR-wt and IKBKB 30UTR -mut,
20 nmol miR-2143p and NC were cotransfected with Lipofectamine
3000 (Invitrogen; Carlsbad, CA, USA) according to the manufacturer’s
instructions. After 48 h incubation, firefly and Renilla luciferase activ-
ities were calculated by the Promega Dual-Luciferase system accord-
ing to the manufacturer’s instructions. Luciferase Assay Reagent II
(LAR II) (Luciferase Assay Reagent, Promega) was used to measure
firefly luciferase activities while Stop & Glo Reagent (Luciferase
Assay Reagent, Promega) was used to measure renilla luciferase
activities. Firefly/Renilla luciferase were measured to evaluate rela-
tive luciferase activity.
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Online databases including miRDB (http://mirdb.org/), Targetscan
(http://www.targetscan.org/) and starbase (http://starbase.sysu.edu.
cn/) were used to predict the targets of miR-2143p. These data
were intersected with NF-kB core genes [28]. A Venn diagram was
constructed to show the overlapping interactions by a web-based
tool (http://bioinformatics.psb.ugent.be/webtools/Venn/).
2.13. Animal experiments
Animal handling and experimental procedures were performed
with the approval from Zhujiang Hospital of Southern Medical Uni-
versity Ethics Committee (LAEC-2019004). A total of 20 adult (aged
10 weeks) male C57BL/6 mice weighing about 25 g were divided into
four groups randomly. Groups included the following: sham with
negative control (NC) (miR-2143p antagomir NC), sham with anta-
gomir (miR-2143p antagomir), OA with NC (miR-2143p agomir
NC), and OA with agomir (miR-2143p agomir). A model of OA was
induced by surgical destabilization of the medial meniscus (DMM)
surgery. Briefly, after anesthetized with amobarbital sodium (25 mg/
kg) intraperitoneally, the right knee joint of mice was exposed to ste-
reomicroscope through a medial capsular incision. Then the medial
meniscotibial ligament was resected, and the medial meniscus was
displaced medially. Finally, the incision was stitched, and the skin
was closed. Mice in the sham and OA groups underwent articular
injection of miR-2143p antagomir or NC and miR-2143p agomir
or NC into the articulation every two weeks. A total of 10 mL solution
(approximately 4 mol/mL) was slowly injected into right knees. All
mice were sacrificed at 70 days after initial surgery or the first injec-
tion. The right knee articulation was harvested to conduct a further
evaluation.
2.14. Histological, immunofluorescence and tunel analysis
The knee joints from human and mice were fixed in 4% PFA (bio-
sharp) and then decalcified with EDTA. For Safranin O-Fast Green
staining, each paraffin-embedded sample was sectioned at 4 mm,
and was stained with 0.2% Safranin O solution for 15 min and 0.2%
Fast Green solution for 5 min (Sigma-Aldrich, USA). For immunofluo-
rescence, after conventional dewaxing, the sections were repaired
with EDTA repair solution in a boiling water bath for 30 min. Then,
0.5% Triton (Regan) was used to permeate the membrane for 20 min
and 5% BSA (MCE, China) was used for blocking for 1 h. After that, the
slices were incubated with primary antibodies (diluted 1:100 by BSA,
MMP3: Abcam Cat# ab52915, RRID: AB_881,243; MMP13:Protein-
tech Cat# 18,1651-AP, RRID: AB_2,144,858) at 4 °C overnight,
washed thrice with PBST and incubated with the fluorescent Alexa
Fluor 555-conjugated secondary antibody (Cell Signaling Technol-
ogy Cat# 4413, RRID: AB_10,694,110) at 37 °C for 1 h. Finally, the
nuclei were stained with DAPI. Fluorescence images were acquired
using Nikon Ti2-E. For TUNEL staining, after incubation with 0.5% Tri-
ton (Regan) for 15 min, rinsing slide(s) three times in PBS for 5 min
each, adding 25 mL TUNEL reaction mixture (Sigma, Roche) on the
section for 1 h at 37 °C in dark. Evaluated the section under a fluores-
cence microscope in the range of 523555 nm (green).
2.15. Statistical analysis
Data are reported as the mean § SEM or SD based on at least trip-
licate samples. Statistical analysis was performed by unpaired two-
tailed Student’s t-test, one-way analysis of variance (ANOVA) or
Mann-Whitney U test for comparisons between groups. P < 0.05
(two-sided) was considered statistically significant for all of the sta-
tistical calculations. PRISM 6.0 (GraphPad Software, San Diego, CA,
USA) was applied to data analysis.2.16. Role of funding source
The funders had no role in study design, data collection, interpre-
tation and analysis, decision to publish or preparation of the manu-
script.
3. Results
3.1. MiR-2143p is decreased in IL-1b stimulated chondrocytes and OA
cartilage tissues
To identify the expression level of miR-2143p in chondrocytes,
we incubated human and mice chondrocytes with IL-1b or vehicle.
We found that IL-1b treatment of human and mice chondrocytes
decreased miR-2143p expression in a time- and dose-dependent
manner (Fig. 1a and b). We then examined the expression of miR-
2143p by ISH and compared its expression level between damaged
and undamaged regions of articular cartilage from human OA
patients. The OA cartilage damaged area exhibited obvious proteogly-
can loss as shown by reduced Safranin O staining and significantly
reduced miR-2143p expression in damaged regions compared with
undamaged regions of arthritic cartilage. In the undamaged cartilage
regions, miR-2143p was located in the cytoplasm of chondrocytes
(Fig. 1c). To determine if downregulated expression of miR-2143p
and increased cartilage degeneration were conserved in an experi-
mental mouse model of OA induced by DMM surgery, ISH analysis
showed an apparent decrease in the number of miR-2143p positive
chondrocytes in OA cartilage compared with sham group (Fig. 1d).
These results indicated that miR-2143p expression was downregu-
lated in inflamed chondrocytes and knee OA cartilage.
3.2. MiR-2143p partially inhibits IL-1b-induced ECM degradation and
apoptosis in HCs
The decreased expression of miR-2143p in OA indicated that
miR-2143p might contribute to its pathogenesis. To test it, we
transfected miR-2143p inhibitor or mimics into chondrocytes and
assessed the effect of miR-2143p on IL-1b-induced ECM degrada-
tion and cell apoptosis. As expected, transfection of chondrocytes
with miR-2143p inhibitor destabilized miR-2143p and caused a
74% decrease in miR-2143p level while miR-2143p was elevated
by 375.7-fold in the cells transfected with miR-2143p mimics com-
pared to the cells transfected with a scramble control (Fig. 2a). To
determine whether miR-2143p in chondrocytes contributes to the
ECM degradation and cell apoptosis, HCs were treated with or with-
out IL-1b in the presence of miR-2143p mimic or inhibitor. MiR-
2143p inhibitor significantly inhibited COL2A1 and SOX9 mRNA lev-
els while increased MMP3 and MMP13 expression (Fig. 2b-e). In con-
trast, transfection of the cells with miR-2143p mimic caused
elevated expression of COL2A1 and SOX9 but decreased expression of
MMP3 and MMP13 (Fig. 2f-i). Consistent with the mRNA levels, west-
ern blotting further confirmed the function of miR-2143p in ECM
metabolism (Fig. 2j and k; Supplementary Fig. 2a-h). To explore the
effects of miR-2143p overexpression or inhibition on IL-1b-induced
HCs apoptosis, we detected apoptosis-related proteins including
cleaved-caspase 3 and Bcl2. The results showed that miR-2143p
inhibition increased the expression of cleaved-caspase 3 and
decreased Bcl2 expression, while miR-2143p overexpression
decreased cleaved-caspase 3 and increased Bcl2 (Fig. 2l and m; Sup-
plementary Fig. 2i-l). To further demonstrate if miR-2143p influen-
ces human chondrocytes apoptosis, immunofluorescence assay of
caspase-3/7 and PI was performed. Caspase 3/7+/PI cells were indic-
ative of early apoptotic cells, while caspase 3/7/PI+ labeled late apo-
ptotic or dead cells. Consistently, IL-1b-induced HCs apoptosis and
cell death was also significantly increased after miR-2143p inhibi-
tion while markedly decreased with miR-2143p overexpression
Fig. 1. MiR-2143p is downregulated in IL-1b stimulated human chondrocytes and OA cartilage tissues. (a) qRT-PCR analysis of miR-2143p expression in primary human chon-
drocytes stimulated with 10 ng/mL IL-1b for 0, 2, 4, 6, 12 or 24 h and at 0, 1, 5, 10, 20, or 40 ng/mL for 24 h. (b) Dose and time-dependent downregulation of miR-2143p expression
in murine primary chondrocytes. (c) Safranin O/fast green staining (left panel) and in situ hybridization (ISH) (right panel) of the cartilage from OA patients. Scale bars, 50 mm. (d)
Safranin O/fast green staining (left panel) and ISH (right panel) of the cartilage from sham or DMM-induced OA mice knee tissues. Scale bars, 50mm. *P<0.05, **P<0.01, ***P<0.001,
****P<0.0001. All data are shown as means § SEM of three independent experiments in (a) and (b). Student’s t-test was used for comparison.
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of miR-2143p partially reversed IL-1b-induced cartilage matrix
degradation and cell apoptosis in HCs.
3.3. MiR-2143p directly targets IKBKB
Numerous studies showed that miRNAs in the cytoplasm could
bind to 30-UTR of target mRNAs and subsequently induce their degra-
dation [10]. MiR-2143p was reported to directly target b-catenin
and inhibit WNT/b-catenin pathway [29, 30]. However, in our study,
we found that miR-2143p had no significant effect on b-catenin
(Supplementary Fig. 3a and b). To explore potential miR-2143p tar-
geting genes associated with NF-kB pathway, we performed bioinfor-
matics analysis with human public database, including miRDB,
TargetScan and starBase and merged them with 17 NF-kB core genes
[28]. The result showed that IKBKB could be the potential targeted
gene of miR-2143p (Fig. 3a). Next, immunofluorescence analysis
detected a significance increase of IKKb expression in the OA-damaged
cartilage as compared to the undamaged cartilage (Fig. 3b). Similar
results were also found in the mice OA models (Supplementary Fig.
3c). qRT-PCR and western blotting analysis results demonstrated thatthe IKBKB mRNA and protein (IKKb) were negatively linked to miR-
2143p in IL-1b-treated HCs (Fig. 3c-f; Supplementary Fig. 3d and e).
Immunofluorescence assays consistently confirmed that miR-2143p
significantly inhibited the expression of IKKb (Fig. 3g). Target predic-
tion algorithms showed that human and mouse IKKb 30UTR regions
were identified as the target of miR-2143p, which contained putative
seed sequences (Fig. 3h). To further verify whether miR-2143p
directly binds with the 30-UTR of IKBKB mRNA, we conducted lucifer-
ase activity assay. MiR-2143pmimics markedly repressed the lucifer-
ase activity of the reporter gene in the cells transfected with wild type
(WT) 30-UTR of IKBKB, but not in those transfected with mutated (Mu)
30-UTR of IKBKB. (Fig. 3i). Taken together, our data showed that miR-
2143p directly targeted IKBKB in chondrocytes.
3.4. MiR-2143p inhibits the activation of NF-kB signaling pathway
IKKb is a pivotal protein phosphorylating IkBa, leading to its deg-
radation and activates the NF-kB signaling pathway. To detect the
activation of NF-kB pathway, we next determined the phosphoryla-
tion of IkBa and p65 in HCs after transfection with miR-2143p
mimics or inhibitor. The results suggested that IL-1b markedly
Fig. 2. MiR-2143p inhibits IL-1b induced extracellular matrix degradation and apoptosis in chondrocytes. (a) Human chondrocytes were transfected with miR-2143p inhibitor
or negative control and miR-2143p mimic or scramble at a final concentration of 30 nM. After 24 h of transfection, miR-2143p levels in human chondrocytes were evaluated by
qRT-PCR. (b-e) qRT-PCR analysis of COL2A1 (b), SOX9 (c),MMP3 (d) andMMP13 (e) in human chondrocytes transfected with miR-2143p inhibitor or negative control with or with-
out IL-1b stimulation. (f-i) qRT-PCR analysis of COL2A1 (f), SOX9 (g), MMP3 (h) and MMP13 (i) in human chondrocytes transfected with miR-2143p mimics or scramble with or
without IL-1b stimulation. (j, k) Western blotting analysis of COL2A1, SOX9, MMP3 and MMP13 protein levels in chondrocytes after miR-2143p inhibition (j) and overexpression
(k). (l, m) Western blotting analysis of cleaved-caspase 3 and Bcl2 expression in chondrocytes after miR-2143p inhibition (l) and overexpression (m). (n) Representative immuno-
fluorescence images of caspase-3/7 (green) and PI (red) after miR-2143p knockdown or overexpression with IL-1b. PI, propidium iodide. Scale bars, 100 mm. (o, p) Quantification
of positive apoptotic cells after miR-2143p inhibition (o) or overexpression (p). ns: no significant difference, *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. All data are shown as
means § SEM of three independent experiments in (a), (b), (c), (d), (e), (k), (f), (g), (h), (i), (o)and (p). Student’s t-test and one-way analysis of variance (ANOVA) were used for com-
parison between two groups and multiple groups, respectively.
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whereas miR-2143p inhibition significantly increased the IkBa and
p65 phosphorylation without alteration of total p65 in IL-1b-stimu-
lated chondrocytes (Fig. 4a). However, miR-2143p overexpression
dramatically decreased p-ikBa and p-p65 (Fig. 4b). As IkBa is an
inhibitor of the nuclear translocation NF-kB dimers (p50p65) iso-
form, we investigated whether miR-2143p delayed NF-kBactivation through suppressing p65 translocation to the nucleus.
Immunofluorescence assays showed that nuclear translocation of
p65 was increased after transfected with miR-2143p inhibitor,
while miR-2143p overexpression exerted opposite effects (Fig. 4c
and d). Collectively, these results suggested that miR-2143p signifi-
cantly suppressed the activation of NF-kB pathway in inflammatory
cytokine stimulated chondrocytes.
Fig. 3. Identification of IKBKB as a direct target of miR-2143p in chondrocytes. (a) Venn diagram display the overlapping of the human target genes of miR-2143p, as predicted by
Targetscan, miRDB, starbase and NF-kB core genes. (b) Immunofluorescence analysis (left) and quantification data (right) of IKKb of human cartilage in undamaged and damaged
areas in OA patients. (c, d) qRT-PCR analysis of IKBKB in human chondrocytes transfected with miR-2143p inhibitor (c) or miR-2143p mimics (d) with or without IL-1b stimula-
tion. (e, f) Western blotting analysis of IKKb protein levels in chondrocytes after miR-2143p inhibition (e) or overexpression (f). The data were normalized by GAPDH. (g) Repre-
sentative images of IKKb assayed by immunofluorescence confocal microscopy in human chondrocytes with miR-2143p knockdown or overexpression with IL-1b. DAPI, 40 ,6-
diamidino-2-phenylindole. Scale bar, 25 mm. (h) Sequence alignment of a putative miR-2143p binding site within the 30-UTR of IKBKB mRNA shows a high level of sequence con-
servation and complementarity with miR-2143p. (i) HEK-293T cells were co-transfected with miR-2143p mimics or scramble and luciferase reporter constructs of the wild-type
IKBKB-30UTR (30UTR-wt) or the mutated IKBKB-30UTR (30UTR mut). Luciferase activity was measured after transfection. Luciferase reporter assay revealed that miR-2143p exclu-
sively decreased luciferase activity of the wild-type reporter plasmids. ns: no significant difference, *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. All data are shown as means §
SEM of three independent experiments in (b), (c), (d) and (i). Student’s t-test and one-way ANOVA were used for comparison between two groups and multiple groups, respec-
tively.
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targeting IKKb
Next, we conducted rescue experiments to examine whether the
effects of miR-2143p expression on OA phenotypes were achieved
through IKKb. Chondrocytes were transfected with two different siR-
NAs (siIKKb1 and siIKKb2) to successfully inhibit IKKb expression
(Fig. 5a). Co-transfection of miR-2143p inhibitor and siIKKb into
chondrocytes reversed the effect of miR-2143p inhibition on down-
regulating COL2A1 and SOX9 expression and increasing the expres-
sion of MMP3 and MMP13 by qRT-PCR (Fig. 5b-e). Changes in the
protein levels of these ECM anabolic and catabolic markers also sup-
ported this reversed effects by western blotting analysis (Fig. 5f; Sup-
plementary Fig. 4a-d). Furthermore, increased cleaved-caspase 3 and
decreased Bcl2 were observed in the IL-1b and miR-2143p inhibitor
group compared with the control group, while cleaved-caspase 3 was
significantly downregulated and Bcl2 was elevated in the group with
siIKKb co-transfection (Fig. 5g; Supplementary Fig. 3e and f).Moreover, immunofluorescence assays suggested that the induction
of cell apoptosis observed after miR-2143p silence was also sup-
pressed by inhibiting IKKb (Fig. 5h). Therefore, our data demon-
strated that miR-2143p inhibited the ECM catabolism and
chondrocyte apoptosis by targeting IKKb.
3.6. Intra-articular (IA) delivery of miR-2143p alleviates OA in mouse
models
To determine the in vivo role of miR-2143p during OA progres-
sion, we conducted IA injection in non-surgical mice with miR-
2143p antagomir (or its NC) and OA mice with miR-2143p agomir
(or NC) for 10 weeks (Fig. 6a and b). Safranin O and Fast Green stain-
ing (SOFG) showed miR-2143p inhibition with antagomir sponta-
neously induced cartilage destruction while miR-2143p
overexpression attenuated OA progression in DMM-induced OA mice
with the injection of miR-2143p agomir (Fig. 6c and d). The staining
also showed that inhibition of miR-2143p might increase the
Fig. 4. MiR-2143p inhibits the activation of NF-kB signaling pathway. (a) Western blotting analysis and quantification data of p-iKBa and p-p65 in chondrocytes after miR-2143p
inhibition. The data were normalized to GAPDH. (b) Western blotting analysis and quantification data of p-iKBa and p-p65 in chondrocytes after miR-2143p overexpression. The
data were normalized to GAPDH. (c, d) Representative images of p65 translocation assayed by immunofluorescence confocal microscopy in human chondrocytes with miR-2143p
knockdown (c) or overexpression (d). DAPI, 40 ,6-diamidino-2-phenylindole. Scale bar, 25 mm. ns: no significant difference, *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. All data
are shown as means § SEM of three independent experiments in (a) and (b). Student’s t-test and one-way ANOVA were used for comparison between two groups and multiple
groups, respectively.
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2143p might attenuate the synovitis and meniscus degeneration
during OA progression (Supplementary Fig. 5). To analyze the effect
of miR-2143p on the catabolic activities of cartilage, we examined
the pathological changes in articular cartilage. The injection of miR-
2143p antagomir aggravated the deteriorative changes in the carti-
lage matrix while miR-2143p agomir alleviated these in OA, as
showed catabolic response (Fig. 6e-h) and decreased apoptotic cells
(Fig. 6i and j) by immunofluorescence. These results revealed that
miR-2143p might impart cartilage protective effects by attenuating
articular cartilage apoptosis and inhibiting ECM catabolism in vivo.
4. Discussion
This study elucidated the biological role of miR-2143p in the
initiation and progression of OA. We presented a pathway in which
inflammatory cytokines induced the downregulation of miR-
2143p in chondrocytes. Decreased miR-2143p activated the NF-
kB signaling pathway and promoted OA development through tar-
geting IKKb (Fig. 6k). Thus, our findings demonstrated that miR-
2143p might be a novel potential therapeutic target for OA pre-
vention and treatment.
MiRNAs, a type of conserved endogenous non-coding RNAs, regu-
late target mRNA expression via translational suppression or mRNA
degradation [31,32]. Evidences have demonstrated that certain miR-
NAs could directly target multiple mRNAs related to the development
of OA, and play crucial roles in mediating the biological functions of
chondrocytes [33,34]. For instance, miR-2185p was upregulated in
OA patients and could target the seed region of the PIK3C2A mRNA
30UTR, leading to articular cartilage degradation [35]. Moreover, miR-
1275p was reported to directly target cartilage matrix protein
MMP13 and regulate Col2a1 expression to stimulate ECM destruction
and cell apoptosis [36]. IA injection of LNA-miR-181a-5p ASO could
reduce loss of chondrocyte components in preclinical models oflumbar facet joint and knee OA [37]. Although miR-2143p were
mainly focused on its down-expression in tumor tissues and its inhi-
bition of apoptosis and promotion of the bone formation, its role in
OA cartilage degradation remained unclear [38,39]. Herein, we found
that miR-2143p had a protective effect against chondrocyte degra-
dation. Overexpression of miR-2143p reduced the expression of the
matrix metalloproteinases, such as MMP3 and MMP13, and inhibited
cell apoptosis but increased the expression of COL2A1 and SOX9.
Therefore, to our knowledge, this is the first report to highlight the
biological significance of miR-2143p in protection of OA.
IKKb belongs to IKK complex that represents an indispensable
member of NF-kB family. Recent studies have indicated that IKKb, in
addition to its role as a initiator of NF-kB pathway activation, could
be involved in maintaining the dynamic homeostasis of ECM micro-
environment [40,41]. For example, icariin could reduce the produc-
tion of inflammatory factors and inhibit chondrocyte apoptosis
through affecting its hub gene IKBKB [42]. Furthermore, pomegranate
fruit extract suppressed the activation of NF-kB pathway by inhibit-
ing the expression of IKKb, thereby exerting chondroprotective effect
[43]. Several studies have demonstrated that miRNAs affected carti-
lage metabolism by inhibiting or activating NF-kB pathway, thus alle-
viating or aggravating the progression of OA [4446]. In our
research, we analyzed the downstream genes of miR-2143p and
found that miR-2143p may target multiple genes. However, our
results suggest that miR-2143p is related to inflammatory factors,
and could directly target IKKb, which could activate NF-kB pathway
to disrupt the equilibrium of ECM metabolism. Moreover, we
revealed that IKKb was upregulated in the joint damaged zone, and
was regulated by miR-2143p. In OA damaged cartilage, decreased
miR-2143p maintained IKKb expression and promoted the activa-
tion of NF-kB pathway. Knockdown of IKKb significantly reversed the
pro-apoptosis and cartilage destruction of a miR-2143p antagonist,
confirming that IKKb was the direct target of miR-2143p to sup-
press ECM degeneration and chondrocyte apoptosis. Hence,
Fig. 5. MiR-2143p exerts biological functions in HCs through targeting IKBKB. (a) Human chondrocytes were transfected with two siRNAs (siIKKb1 and siIKKb2) at a final con-
centration of 30 nM. After 48 h of transfection, the knockout efficiency of IKKb was demonstrated by western blot. GAPDH was used as the internal control. (b-e) qRT-PCR analysis
of COL2A1 (b), SOX9 (c), MMP3 (d) and MMP13 (e) in human chondrocytes with miR-2143p inhibition or a combination of miR-2143p and IKKb inhibition with or without IL-1b
stimulation. (f) Western blotting analysis of COL2A1, SOX9, MMP3, MMP13 protein levels in chondrocytes after miR-2143p inhibition or a combination of miR-2143p and IKKb
inhibition. The data were normalized to GAPDH. (g) Western blotting analysis of cleaved-caspase 3 and Bcl2 expression in chondrocytes after miR-2143p inhibition or a combina-
tion of miR-2143p and IKKb inhibition. The data were normalized to GAPDH. (h) Representative immunofluorescence images of caspase-3/7 (green) and PI (red) after miR-
2143p knockdown or/with IKKb inhibition (left) and the quantification (right). PI, propidium iodide. Scale bars, 100 mm. ns: no significant difference, *P<0.05, **P<0.01,
***P<0.001, ****P<0.0001. All data are shown as means § SEM of three independent experiments in (b), (c), (d), (e) and (h). Student’s t-test and one-way ANOVA were used for com-
parison between two groups and multiple groups, respectively.
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light on the prevention and treatment of OA.
IA miRNA treatments have come to light in recent years. Clinicians
may have more options to provide patients with effective and reliable
therapies that have fewer side effects [47]. In previous studies, IA
gene delivery systems mainly focused on LNA-miR-ASO, lentiviruses,
adenovirus vectors and atelocollagen [37,48,49]. These biologic deliv-
ery systems have exhibited good safety, but they may have biotoxic
effects or off-target effects. Currently, a plenty of studies have
reported the application of modified miRNAs in the joint. Si et al.
demonstrated that IA injection of miRNA-140 attenuated OA progres-
sion by regulating ECM dynamic balance, and may serve as a new
therapeutic agent for the treatment of OA [50]. Wang et al. reported
that IA injection of synthetic antago-miR-4835p suppressed chon-
drocyte hypertrophy, cartilage and ECM destruction, and conse-
quently delayed the onset of OA [51]. In this study, miRNA-2143p
agomir, a specially modified miRNA agonist, was administered intra-
articularly in DMM-induced OA mouse model. Our results showed
that overexpression miR-2143p could ameliorate surgically induced
OA in mice. Therefore, our study indicates that miR-2143p delivery
may be a promising way in the treatment of OA. Further study will be
conducted to confirm its therapeutic potential in humans.This study has some limitations. First, according to the data from
miRbase, miR-2143p is homologous to human and mouse. We
investigated the involvement of miR-2143p in regulating human
chondrocytes ECM metabolism and cell apoptosis and explored its
possible underlying molecular mechanisms in OA pathogenesis both
in vitro and in vivo. Our results suggested that miR-2143p was
decreased after IL-1b stimulation in both human and mice primary
chondrocytes. Thus, it is reasonable to suppose that miR-2143p can
exert the protective effects in mice primary chondrocytes. Of note,
the mechanism of the decrease in miR-2143p levels during the
deteriorative process remains undetectable. Previous studies
revealed that m6A mark acted as a key post-transcriptional modifica-
tion that promoted the initiation of miRNA biogenesis [52]. More-
over, H3K4me3 demethylase, bound to the miRNA promoter, which
led to inhibition of its transcription and expression [53]. SnoRNAs,
involving in ribosome biogenesis and RNA modification, acted as
endogenous sponges that regulate miRNA expression [54]. These
studies suggested that several mechanism were involved in miRNA
biogenesis. In this study, we found that decreased miR-2143p acti-
vated NF-kB pathway and promoted osteoarthritis. However, the
detailed mechanism that inflammatory cytokines induce the
decrease of miR-2143p remains further investigation.
Fig. 6. MiR-2143p alleviates OA in vivo. (a-b) Schematic diagram showing the design of the OA therapeutic experiment targeting miR-2143p. (c) Mice in spontaneous group
were injected with miR-2143p antagomir or antagomir NC, while DMM-induced OA mice were injected with miR-2143p agomir or agomir NC. The articular cartilage was
stained with Safranin-O/Fast green (SOFG). Scale bars, 100 mm. (d) OARSI scoring was measured according to SOFG staining results (n = 4 mice per group). (e, g) Expression of
MMP3 (e) and MMP13 (g) in articular cartilage were detected by immunofluorescence. Scale bars, 400 mm. (f, h) Quantification of (e) and (g) (n = 4 mice per group). (i) TUNEL stain-
ing of the chondrocytes in cartilage (CC) and articular cartilage (AC) in the indicated groups at 10 weeks (n = 4 mice per group). Blue fluorescence (DAPI) indicating total cells; green
fluorescence (fluorescein isothiocyanate) indicating TUNEL positive cells. Scale bars, 100 mm. (j) Quantification of E (n = 4 mice per group). ns: no significant difference, *P<0.05,
**P<0.01, ***P<0.001, ****P<0.0001. Means § 95% confidence interval (CI) with Mann-Whitney U test for OARSI score in (d). Data are shown as means § SD in (f) (h) and (j). Stu-
dent’s t-test was used for comparison in (f) (h) and (j). OARSI, Osteoarthritis Research Society International. TUNEL, terminal dexynucleotidyl transferase(TdT)-mediated dUTP nick
end labeling. (k) Schematic of the working hypothesis. The downregulation of miR-2143p in the inflammatory cytokines-stimulated human chondrocytes and OA cartilage tissues
is directly associated with ECM catabolism and cell apoptosis. MiR-2143p inhibits NF-kB pathway by directly targeting IKKb.
10 Y. Cao et al. / EBioMedicine 65 (2021) 103283In conclusion, our study revealed the biological role of miR-
2143p in OA development. Decreased miR-2143p promotes
ECM degradation and chondrocyte apoptosis via activation of NF-
kB pathway. Intra-articular delivery of miR-2143p agomir may
be a novel promising approach in OA therapy.Contributions
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